These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Emwas AH Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154 [TBL] [Abstract][Full Text] [Related]
6. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963 [TBL] [Abstract][Full Text] [Related]
7. Problems, principles and progress in computational annotation of NMR metabolomics data. Judge MT; Ebbels TMD Metabolomics; 2022 Dec; 18(12):102. PubMed ID: 36469142 [TBL] [Abstract][Full Text] [Related]
8. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics. Marshall DD; Powers R Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170 [TBL] [Abstract][Full Text] [Related]
9. Practical Aspects of NMR-Based Metabolomics. Wishart DS; Rout M; Lee BL; Berjanskii M; LeVatte M; Lipfert M Handb Exp Pharmacol; 2023; 277():1-41. PubMed ID: 36271165 [TBL] [Abstract][Full Text] [Related]
10. Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics. Bingol K; Brüschweiler R Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):471-7. PubMed ID: 26154280 [TBL] [Abstract][Full Text] [Related]
11. NMR Spectroscopy-Based Metabolic Profiling of Biospecimens. Sengupta A; Weljie AM Curr Protoc Protein Sci; 2019 Dec; 98(1):e98. PubMed ID: 31763785 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Multivariate Classification Models for Analyzing NMR Metabolomics Data. Vu T; Siemek P; Bhinderwala F; Xu Y; Powers R J Proteome Res; 2019 Sep; 18(9):3282-3294. PubMed ID: 31382745 [TBL] [Abstract][Full Text] [Related]
13. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308 [TBL] [Abstract][Full Text] [Related]
14. A review of strategies for untargeted urinary metabolomic analysis using gas chromatography-mass spectrometry. Khodadadi M; Pourfarzam M Metabolomics; 2020 May; 16(6):66. PubMed ID: 32419109 [TBL] [Abstract][Full Text] [Related]
15. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument? Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617 [TBL] [Abstract][Full Text] [Related]
16. New tools and resources in metabolomics: 2016-2017. Misra BB Electrophoresis; 2018 Apr; 39(7):909-923. PubMed ID: 29292835 [TBL] [Abstract][Full Text] [Related]
17. Spectral relative standard deviation: a practical benchmark in metabolomics. Parsons HM; Ekman DR; Collette TW; Viant MR Analyst; 2009 Mar; 134(3):478-85. PubMed ID: 19238283 [TBL] [Abstract][Full Text] [Related]
18. PeakForest: a multi-platform digital infrastructure for interoperable metabolite spectral data and metadata management. Paulhe N; Canlet C; Damont A; Peyriga L; Durand S; Deborde C; Alves S; Bernillon S; Berton T; Bir R; Bouville A; Cahoreau E; Centeno D; Costantino R; Debrauwer L; Delabrière A; Duperier C; Emery S; Flandin A; Hohenester U; Jacob D; Joly C; Jousse C; Lagree M; Lamari N; Lefebvre M; Lopez-Piffet C; Lyan B; Maucourt M; Migne C; Olivier MF; Rathahao-Paris E; Petriacq P; Pinelli J; Roch L; Roger P; Roques S; Tabet JC; Tremblay-Franco M; Traïkia M; Warnet A; Zhendre V; Rolin D; Jourdan F; Thévenot E; Moing A; Jamin E; Fenaille F; Junot C; Pujos-Guillot E; Giacomoni F Metabolomics; 2022 Jun; 18(6):40. PubMed ID: 35699774 [TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer. Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T Anal Bioanal Chem; 2020 Sep; 412(23):5827-5841. PubMed ID: 32661677 [TBL] [Abstract][Full Text] [Related]